Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN110438194B details a novel lipase F11 for resolving DL-tropine methyl ester with >99% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN111500652A reveals a novel enzymatic dynamic kinetic resolution for florfenicol. Discover cost-effective, high-purity veterinary drug intermediate manufacturing solutions.
Patent CN113481181B details a novel esterase mutant for resolving indoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN101883486B reveals non-chromatographic resolution. Enables cost reduction in pharmaceutical intermediate manufacturing via crystallization.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Patent CN113201516B reveals a solvent-free enzymatic route for L-menthol with >95% ee. Discover cost-effective manufacturing solutions for high-purity terpene alcohols.
Patent CN107011228B details a novel chiral resolution process for Clemastine Fumarate ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel scalable route for (3R,6S)-1-benzyl-6-methylpiperidine-3-amine avoiding chiral chromatography, offering cost-effective API manufacturing solutions.
Patent CN118026867B details a high-efficiency chiral resolution for Mirogabalin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced synthesis of chiral tetrahydroquinoline derivatives via diastereomeric resolution. Reliable supplier for scalable API intermediates with optimized cost structures.
Patent CN101654445B reveals a cost-effective route for Ramelteon intermediates using mild conditions. This ensures supply chain stability and high purity for global pharmaceutical manufacturers seeking reliable partners.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Advanced enzymatic synthesis patent analysis for high-purity Clopidogrel intermediates. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107759623A reveals high-yield Ruxolitinib intermediate route. Eliminates column chromatography for cost reduction and supply chain reliability in API manufacturing.
Patent CN107759601A details high-purity Ruxolitinib synthesis. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN106008318B reveals advanced chiral dye synthesis for OLED. Discover cost reduction in electronic chemical manufacturing and high-purity supply solutions.